| Literature DB >> 35055458 |
Ali Allam1, Ahmed Abdeen2,3, Hari Prasad Devkota4, Samar S Ibrahim2, Gehan Youssef2, Ahmed Soliman5, Mohamed M Abdel-Daim6,7, Khalid J Alzahrani8, Khaled Shoghy9, Samah F Ibrahim10, Mohamed Aboubakr1.
Abstract
Deltamethrin (DLM) is a synthetic pyrethroid with anti-acaricide and insecticidal properties. It is commonly used in agriculture and veterinary medicine. Humans and animals are exposed to DLM through the ingestion of polluted food and water, resulting in severe health issues. N-acetylcysteine (NAC) is a prodrug of L-cysteine, the precursor to glutathione. It can restore the oxidant-antioxidant balance. Therefore, this research aimed to examine whether NAC may protect broiler chickens against oxidative stress, at the level of biochemical and molecular alterations caused by DLM intoxication. The indicators of liver and kidney injury in the serum of DLM-intoxicated and NAC-treated groups were examined. Furthermore, lipid peroxidation, antioxidant markers, superoxide dismutase activity, and apoptotic gene expressions (caspase-3 and Bcl-2) were investigated. All parameters were significantly altered in the DLM-intoxicated group, suggesting that DLM could induce oxidative damage and apoptosis in hepato-renal tissue. The majority of the changes in the studied parameters were reversed when NAC therapy was used. In conclusion, by virtue of its antioxidant and antiapoptotic properties, NAC enabled the provision of significant protection effects against DLM-induced hepato-renal injury.Entities:
Keywords: Bcl2; N-acetylecystine; antioxidant; caspase3; deltamethrin; hepato-renal toxicity
Mesh:
Substances:
Year: 2022 PMID: 35055458 PMCID: PMC8775898 DOI: 10.3390/ijerph19020638
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Chemical structures of deltamethrin and N-acetylcysteine.
The formulation of the basal diet for broilers.
| Ingredients | Starter Diet | Finisher Diet |
|---|---|---|
| Yellow corn | 58.57 | 64 |
| Soyabean meal (48%) | 32 | 25 |
| Corn gluten (60%) | 5 | 5 |
| Soybean oil | 0.7 | 2.5 |
| Di-calcium phosphate (22% Ca and 19% Ph) | 1.5 | 0.95 |
| Limestone (35% Ca) | 1.7 | 1.74 |
| Common salts | 0.2 | 0.15 |
| Methionine (95%) | 0.13 | 0.36 |
| Lysine (98%) | 0 | 0.1 |
| Vitamins and mineral premix * | 0.2 | 0.2 |
|
| ||
| Protein (%) | 23 | 20 |
| k. calory ME/kg | 2950 | 3120 |
| Calcium (%) | 1 | 0.9 |
| Phosphorus (%) | 0.48 | 0.35 |
* Each 2 kg contain the following vitamins and minerals: Vit. A 12 MIU, Vit. D3 2 MIU, Vit. E 1000 mg, Vit. k3 1000 mg, Vit. B1 1000 mg, Vit. B2 5000 mg, Vit. B6 1500 mg, Vit. B12 10 mg, biotin 50 mg, pantothinic acid 10 g, nicotinic acid 30 g, folic acid 1000 mg, manganese 60 g, zinc 50 g, iron 30 g, copper 4 g, iodine 300 mg, selenium 100 mg, cobalt 100 mg, carrier (CaCO3) to 3 kg. (Vitamin-mineral premix for poultry, Agrivet Pharma, Cairo, Egypt).
Primer pairs sequences of caspase3, Bcl2, and β-actin genes.
| Gene Name | Primer Sequence (5′-3′) | Reference |
|---|---|---|
|
| F: TGGCCCTCTTGAACTGAAAG | [ |
|
| F: ATCGTCGCCTTCTTCGAGTT | [ |
|
| F: CCACCGCAAATGCTTCTAAAC | [ |
Effect of DLM and/or NAC on growth performance.
| Parameters | Control | NAC | DLM | DLM+NAC |
|---|---|---|---|---|
| B. wt (7 days; g) | 143.80 ± 0.50 a | 144.13 ± 0.97 a | 139.27 ± 0.41 b | 143.27 ± 1.01 a |
| B. wt (35 days; g) | 1938.6 ± 2.11 b | 2119.6 ± 1.73 a | 1526.7 ± 8.70 d | 1761.9 ± 8.92 c |
| Weight gain (g) | 1794.8 ± 2.28 b | 1975.5 ± 1.52 a | 1387.5 ± 8.76 d | 1618.6 ± 9.08 c |
| Feed intake (g) | 3254.3 ± 2.48 c | 3383.3 ± 7.17 a | 3931.7 ± 2.63 d | 3286.3 ± 13.10 b |
| FCR (%) | 1.81 ± 0.002 c | 1.71 ± 0.004 d | 2.11 ± 0.013 a | 2.03 ± 0.016 b |
All data are expressed means ± SE (n = 3). B. wt; body weight, FCR; feed conversion ratio. The means with different superscript letters are considerad statistically significant at p ≤ 0.05 in the same raw.
Figure 2Effect of DLM and/or NAC treatments on the hepato-renal function. The values are expressed using the mean ± SE (n = 3). The statistically significant difference (p ≤ 0.05) is indicated by different superscript characters.
Figure 3Effect of DLM and/or NAC treatments on hepatic and renal oxidative indexes. The values are expressed using the mean ± SE (n = 3). The statistically significant difference (p ≤ 0.05) is indicated by different superscript characters.
Figure 4Effect of DLM and/or NAC treatments on caspase3 and Bcl2 mRNA expression levels. The values are expressed using the fold changes ± SE (n = 3), after normalization against the endogenous control (β-actin). The statistically significant difference (p ≤ 0.05) is indicated by different superscript characters.
Figure 5Changes in the liver histopathology after treatment with DLM and/or NAC. (A) Control group (scale bar = 50 µm), (B) NAC group (scale bar = 50 µm), (C) DLM (scale bar = 200 µm); and (D) DM+NAC (scale bar = 100 µm). c: Central vein, h: hepatic lobules, l: inflammatory cells infiltration. (H&E stain).
Figure 6Changes in the kidney histopathology after treatment with DLM and/or NAC. (A) Control group (scale bar = 50 µm), (B) NAC group (scale bar = 50 µm), (C) DLM (scale bar = 50 µm); and (D) DM+NAC (scale bar = 100 µm). G: Glomerulus, P: proximal tubule, D: distal tubule (H&E stain).
Figure 7The proposed mechanistic insights associated with the protective activity of NAC against DLM-induced toxicity.